Kevin Mickela

Kevin Mickela is a Development Scientist at Freenome since September 2022, with previous experience as a Scientist II at Alexion Pharmaceuticals from August 2019 to April 2022, where responsibilities included analytical method development and qualification for biotherapeutic programs. Prior to that role, Kevin served as a Specialist in Impurities Analysis at Bayer Pharmaceuticals from July 2014 to August 2019, focusing on impurity analysis testing for drug products. Kevin's career began at Bio-Rad Laboratories as a Senior Research Associate from August 2006 to June 2014, developing diagnostic immunoassays, and started as a Pharmacy Technician at Longs Drugs from June 2001 to August 2006. Kevin holds a Bachelor of Science in Biology from California State University-Sacramento, earned between 2004 and 2006, and studied at the University of the Pacific from 2001 to 2003.